Single blind randomized controlled clinical study to evaluate the efficacy and safety of shivagutika in dyslipidemia
Journal name: International Ayurvedic Medical Journal
Original article title: Single blind randomized controlled clinical study to evaluate the efficacy and safety of shivagutika in dyslipidemia
The International Ayurvedic Medical Journal (IAMJ) is a peer-reviewed scientific publication dedicated to Ayurveda. It aims to integrate Ayurvedic concepts with modern scientific understanding, offering a comprehensive source of validated knowledge for both the modern Ayurvedic community and the broader medical fraternity.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Gajanana Hegde
Sanjay Kumar M.D.
Caroline Theresa Cutinha
Download the PDF file of the original publication
International Ayurvedic Medical Journal:
(Publishing full-length original papers and reviews on ayurveda)
Full text available for: Single blind randomized controlled clinical study to evaluate the efficacy and safety of shivagutika in dyslipidemia
Year: 2018
Copyright (license): CC BY-NC-ND 3.0
Summary of article contents:
Objective: To evaluate the effect and safety of trial drug dyslipidemia and comparison with control drug trolled clinical study of 45 days duration with pre and post test assessment. 60 patients diagnosed with dyslipidemia were randomly selected and assigned into two groups, Group A (Control) and Group B (Test), each group consisting minimum of 30 patients. G ceived Shiva Gutika for 45 days. Blood samples of both the groups for Lipid profile, Apolipoprotein B and Safety Assessment were evaluated before starting the treatment (0 day). Results: Both Group A & Group B drugs showed significant result in reducing Lipid Profile & Apolipoprotein B in Dyslipidemia. ShivagutikaLipid profile like S. Triglycerides, LDL, HDL, VLDL, Total Cholesterol and Cholesterol/HDL ratio. On Apolipoprotein B Navaka Guggulu showed better results than result obtained in this study support the hypothesis i.e trial drug design Shivagutika when compared to assessment of drugs both clinically & statistically shows a significant result, which implies that th control group are safe in this study design for the said interval, for the said duration & for the said dosage Keywords: Shiva Gutika, Navaka Guggulu INTRODUCTION Hyperlipidemia, hyperlipoproteinemia or dyslipidemia is the condition of abnormally elevated level of any or all lipids and
Other Health Sciences Concepts:
Discover the significance of concepts within the article: ‘Single blind randomized controlled clinical study to evaluate the efficacy and safety of shivagutika in dyslipidemia’. Further sources in the context of Health Sciences might help you critically compare this page with similair documents:
Ayurveda, Vamana, Snehapana, Heart disease, Group A, Group (b), Serum cholesterol, Dyslipidemia, Total cholesterol, Lipid profile, Cardiovascular disease, Government Ayurveda medical college, Shiva Gutika, Safety assessment, Apolipoprotein B, Navaka Guggulu, Statistical method, LDL, HDL, VLDL.